The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treatment of multi-resistant falciparum malaria.
D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000627:therapeutic use*; D013411:Sulfadiazine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D013449:Sulfonamides; D013411:Sulfadiazine; D011739:Pyrimethamine